Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patients.
about
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adultsQuantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.The glory of guidelines and the twilight of reality: controversies and challenges in the prevention and treatment of HIV in children.PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics
P2860
Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Steady-state pharmacokinetics ...... V-infected pediatric patients.
@ast
Steady-state pharmacokinetics ...... V-infected pediatric patients.
@en
type
label
Steady-state pharmacokinetics ...... V-infected pediatric patients.
@ast
Steady-state pharmacokinetics ...... V-infected pediatric patients.
@en
prefLabel
Steady-state pharmacokinetics ...... V-infected pediatric patients.
@ast
Steady-state pharmacokinetics ...... V-infected pediatric patients.
@en
P2093
P2860
P356
P1476
Steady-state pharmacokinetics ...... V-infected pediatric patients.
@en
P2093
Andrew Wiznia
Bobbie Graham
Edward P Acosta
Jennifer R King
P1058 Protocol Team
Patrick Jean-Philippe
Paula Britto
Rohan Hazra
Vincent Carey
P2860
P304
P356
10.1128/AAC.01334-10
P407
P577
2011-06-13T00:00:00Z